Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas
Abstract
BACKGROUND AND PURPOSE: Noninvasive radiologic evaluation of glioma can facilitate correct diagnosis and detection of malignant transformation. Although positron-emission tomography is considered valuable in the care of patients with gliomas, 18F-fluorodeoxyglucose and 11C-methionine have reportedly shown ambiguous results in terms of grading and prognostication. The present study compared the diagnostic and prognostic capabilities of diffusion tensor imaging, FDG, and 11C-methionine PET in nonenhancing gliomas.
MATERIALS AND METHODS: Thirty-five consecutive newly diagnosed, histologically confirmed nonenhancing gliomas that underwent both FDG and 11C-methionine PET were retrospectively investigated (23 grade II and 12 grade III gliomas). Apparent diffusion coefficient, fractional anisotropy, and tumor-to-normal tissue ratios of both FDG and 11C-methionine PET were compared between grade II and III gliomas. Prognostic values of these parameters were also tested by using progression-free survival.
RESULTS: Grade III gliomas showed significantly higher average tumor-to-normal tissue and maximum tumor-to-normal tissue than grade II gliomas in 11C-methionine (P = .013, P = .0017, respectively), but not in FDG-PET imaging. There was no significant difference in average ADC, minimum ADC, average fractional anisotropy, and maximum fractional anisotropy. 11C-methionine PET maximum tumor-to-normal tissue ratio of 2.0 was most suitable for detecting grade III gliomas among nonenhancing gliomas (sensitivity, 83.3%; specificity, 73.9%). Among patients not receiving any adjuvant therapy, median progression-free survival was 64.2 ± 7.2 months in patients with maximum tumor-to-normal tissue ratio of <2.0 for 11C-methionine PET and 18.6 ± 6.9 months in patients with maximum tumor-to-normal tissue ratio of >2.0 (P = .0044).
CONCLUSIONS: 11C-methionine PET holds promise for World Health Organization grading and could offer a prognostic imaging biomarker for nonenhancing gliomas.
Abbreviations
- MET
- 11C-methionine
- PFS
- progression-free survival
- T/N
- tumor-to-normal tissue
- T/Nave
- average tumor-to-normal tissue
- T/Nmax
- maximum tumor-to-normal tissue
- © 2016 American Society of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org
Jump to section
Related Articles
Cited By...
- Prognostic Value of the Metabolic and Volumetric Parameters of 11C-Methionine Positron-Emission Tomography for Gliomas: A Systematic Review and Meta-Analysis
- Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker, Tatjana Traub-WeidingerJournal of Nuclear Medicine 2018 59 6
- C. Deuschl, J. Kirchner, T. D. Poeppel, B. Schaarschmidt, S. Kebir, N. El Hindy, J. Hense, H. H. Quick, M. Glas, K. Herrmann, L. Umutlu, C. Moenninghoff, A. Radbruch, M. Forsting, M. SchlamannEuropean Journal of Nuclear Medicine and Molecular Imaging 2018 45 4
- Yae Won Park, Yoon Seong Choi, Sung Soo Ahn, Jong Hee Chang, Se Hoon Kim, Seung-Koo LeeKorean Journal of Radiology 2019 20 9
- Gloria C. Chiang, Ilhami Kovanlikaya, Changho Choi, Rohan Ramakrishna, Rajiv Magge, Dikoma C. ShunguFrontiers in Neurology 2018 9
- Anna Falk Delgado, Alberto Falk DelgadoThe British Journal of Radiology 2018
- Laszlo Papp, Clemens P. Spielvogel, Ivo Rausch, Marcus Hacker, Thomas BeyerFrontiers in Physics 2018 6
- Hiroaki Takei, Jun Shinoda, Soko Ikuta, Takashi Maruyama, Yoshihiro Muragaki, Tomohiro Kawasaki, Yuka Ikegame, Makoto Okada, Takeshi Ito, Yoshitaka Asano, Kazutoshi Yokoyama, Noriyuki Nakayama, Hirohito Yano, Toru IwamaJournal of Neurosurgery 2020 133 4
- Olivia Näslund, Anja Smits, Petter Förander, Mats Laesser, Jiri Bartek, Jens Gempt, Ann Liljegren, Eva-Lotte Daxberg, Asgeir Store JakolaActa Neurochirurgica 2018 160 7
- Natale Quartuccio, Riccardo Laudicella, Antonio Vento, Salvatore Pignata, Maria Vittoria Mattoli, Rossella Filice, Alessio Danilo Comis, Annachiara Arnone, Sergio Baldari, Manlio Cabria, Angelina CistaroDiagnostics 2020 10 6
- Nina Poetsch, Adelheid Woehrer, Johanna Gesperger, Julia Furtner, Alexander R Haug, Dorothee Wilhelm, Georg Widhalm, Georgios Karanikas, Michael Weber, Ivo Rausch, Markus Mitterhauser, Wolfgang Wadsak, Marcus Hacker, Matthias Preusser, Tatjana Traub-WeidingerNeuro-Oncology 2018 20 3